Post

India’s Bharat Serums Expands Manufacturing Facilities

India’s Bharat Serums Expands Manufacturing Facilities

Mumbai-headquartered Bharat Serums and Vaccines Limited (BSV) hosted the groundbreaking ceremony of its new manufacturing plant at Genome Valley in Hyderabad, Telengana. The company is owned by Advent, an American private equity fund.

Spread across 10 acres, the  $22 million manufacturing facility will increase the company’s capacity to produce injectables with the commissioning of the fill-finish formulation line in Phase I, and an additional multi-product line in Phase II of the project.

The company currently has a manufacturing facility in Ambernath, Maharashtra, that caters to domestic and more than 80 export markets. It also has a manufacturing facility in Aachen, Germany, that serves the international markets.

BSV is amongst the top 10 biotech companies in India and has a portfolio of over 145 brands. It plans to produce women’s health products, anti-rabies vaccines, immunoglobulins and hormones, among others  products.

Share

About Amritt

Who We Are

Small or big, your business will love our financial help and business consultations! We are happy when our clients are too… Actually, this is quite simple to achieve – because each time we help them in sorting out different accounting intricacies or save the day before filing the taxes, they are happy indeed! And so are we.   

We have over Twenty years of experience helping our clients succeed in India
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Blog
Page
Dictionary
Comparisons
Capabilities
India Business Guide
Services
Private
Speaking
Insights
White Papers
News
Newsletters
Clients
Case Studies
Companies In India
Webinars
Presentations
Industries